Cargando…

CD74 interacts with APP and suppresses the production of Aβ

BACKGROUND: Alzheimer disease (AD) is characterized by senile plaques, which are mainly composed of β amyloid (Aβ) peptides. Aβ is cleaved off from amyloid precursor protein (APP) with consecutive proteolytic processing by β-secretase and γ-secretase. RESULTS: Here, we show that CD74, the invariant...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuda, Shuji, Matsuda, Yukiko, D'Adamio, Luciano
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770512/
https://www.ncbi.nlm.nih.gov/pubmed/19849849
http://dx.doi.org/10.1186/1750-1326-4-41
Descripción
Sumario:BACKGROUND: Alzheimer disease (AD) is characterized by senile plaques, which are mainly composed of β amyloid (Aβ) peptides. Aβ is cleaved off from amyloid precursor protein (APP) with consecutive proteolytic processing by β-secretase and γ-secretase. RESULTS: Here, we show that CD74, the invariant chain of class II major histocompatibility complex, interacts with APP and serves as a negative regulator of Aβ. CD74 resembles other APP interacters such as BRI2 and BRI3, since all of them reduce the level of Aβ. However, unlike BRIs, CD74 does not reduce the secretion of sAPPα or sAPPβ. Interestingly, in HeLa cells, over expression of CD74 steers APP, but not Notch, to large vacuoles created by CD74. CONCLUSION: Taken together, we propose that CD74 inhibits Aβ production by interacting with and derailing normal trafficking of APP.